-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The outbreak of the epidemic in Hong Kong, the 28 yuan Lianhua Qingwen capsule in the pharmacy was fired to 100 yuan, and the price soared by 257%
.
.
28 yuan Lianhua Qingwen, the hype price can reach 100 yuan
On February 15, the Centre for Health Protection of the Department of Health of the Hong Kong Special Administrative Region Government announced that as of 0:00 that day, there were 1,619 new confirmed cases of new coronary pneumonia in Hong Kong (all local cases)
.
At present, the cumulative number of confirmed cases of new coronary pneumonia in Hong Kong is 26,670
.
.
At present, the cumulative number of confirmed cases of new coronary pneumonia in Hong Kong is 26,670
.
Recently, the Hong Kong media "Toutiao Daily" reported that under the severe epidemic situation in Hong Kong, the people set off a rush to buy Lianhua Qingwen
.
The reporter visited a number of pharmacies and found that Lianhua Qingwen was in short supply.
Some chain stores were out of stock a week ago
.
.
The reporter visited a number of pharmacies and found that Lianhua Qingwen was in short supply.
Some chain stores were out of stock a week ago
.
In addition, according to Hong Kong Wenhui.
com, a local pharmacy with Lianhua Qingwen did not sell it even if it had stock on that day
.
At present, the 28 yuan/box of Lianhua Qingwen capsules starts from 50 yuan and can reach up to 100 yuan, an increase of 257%
.
com, a local pharmacy with Lianhua Qingwen did not sell it even if it had stock on that day
.
At present, the 28 yuan/box of Lianhua Qingwen capsules starts from 50 yuan and can reach up to 100 yuan, an increase of 257%
.
Li Xiaowen, a doctor of traditional Chinese medicine in Hong Kong , pointed out that the effect of Lianhua Qingwen is to clear the fever and detoxify, and it is effective for the treatment and prevention of fever, nasal congestion, headache, sore throat and other mild symptoms
.
Many people in Hong Kong use Lianhua Qingwen as a body medicine, and use Chinese herbal medicines such as honeysuckle and forsythia to detoxify and relieve discomfort.
This is traditional Chinese folk wisdom, but the public should find a registered Chinese medicine practitioner for dispensing
.
.
Many people in Hong Kong use Lianhua Qingwen as a body medicine, and use Chinese herbal medicines such as honeysuckle and forsythia to detoxify and relieve discomfort.
This is traditional Chinese folk wisdom, but the public should find a registered Chinese medicine practitioner for dispensing
.
Behind the daily limit of the stock price is a good epidemic prevention strength
Affected by the related epidemic, the stock price of Yiling Pharmaceutical, the exclusive manufacturer of Lianhua Qingwen, showed signs of rapid rise yesterday
.
.
According to Oriental Fortune data, when the market opened on February 15, Yiling Pharmaceutical’s stock price was 21.
66 yuan, a decrease of -6.
03%.
In less than half an hour, the stock price rushed to 23.
99 yuan, an increase of 4.
08%, and the daily limit was directly raised; on the morning of February 16, the stock price overall Maintaining an upward trend, it reached 25.
03 yuan at around 10 points, an increase of 8.
59%
.
66 yuan, a decrease of -6.
03%.
In less than half an hour, the stock price rushed to 23.
99 yuan, an increase of 4.
08%, and the daily limit was directly raised; on the morning of February 16, the stock price overall Maintaining an upward trend, it reached 25.
03 yuan at around 10 points, an increase of 8.
59%
.
Behind the rise in stock prices, Lianhua Qingwen has become a star drug for epidemic prevention that has attracted much attention across the country, and is generally recognized
.
.
For example, in the fourth to eighth editions of the National "New Coronavirus Pneumonia Diagnosis and Treatment Program", as well as in the diagnosis and treatment programs of many provinces and cities across the country, Chinese patent medicines such as Lianhua Qingwen have been continuously recommended
.
.
In April 2020, Yiling Pharmaceutical issued a document stating that, with the approval of the State Food and Drug Administration, "new type of coronavirus pneumonia mild, common type" has been added to the original indications of Lianhua Qingwen Capsules and Lianhua Qingwen Granules
.
.
In addition, the international medical journal "Plant Medicine" published papers by academicians Zhong Nanshan, Li Lanjuan, and Zhang Boli also said that on the basis of conventional treatment, combined application of Lianhua Qingwen Capsules for 14 days can significantly improve the clinical cure rate of patients with new coronary pneumonia.
The treatment effect of fatigue, cough and other symptoms is obvious, and the safety is high
.
The treatment effect of fatigue, cough and other symptoms is obvious, and the safety is high
.
Not only at home, but also Lianhua Qingwen's response overseas is also good
.
.
In July 2021, Lianhua Qingwen was selected as the home treatment plan for mild patients with new coronary pneumonia in Cambodia .
This is the first case of Chinese medicines
entering foreign new coronary pneumonia treatment plans .
At present, Lianhua Qingwen has obtained registration approval or import license in nearly 30 countries and regions
.
This is the first case of Chinese medicines
entering foreign new coronary pneumonia treatment plans .
At present, Lianhua Qingwen has obtained registration approval or import license in nearly 30 countries and regions
.
Lianhua Qingwen Capsules ranked second in the pharmacy market
In addition to epidemic prevention, Lianhua Qingwen itself has achieved remarkable sales results
.
.
According to data from Minet.
com, in 2020, the sales of Chinese patent medicines for colds in Chinese urban physical pharmacies will exceed 11 billion yuan
.
Among them, Lianhua Qingwen Capsules were 1.
534 billion yuan, ranking second in the market, second only to Ganmaoling Granules; Lianhua Qingwen Granules were 219 million yuan, ranking 13th in the market
.
com, in 2020, the sales of Chinese patent medicines for colds in Chinese urban physical pharmacies will exceed 11 billion yuan
.
Among them, Lianhua Qingwen Capsules were 1.
534 billion yuan, ranking second in the market, second only to Ganmaoling Granules; Lianhua Qingwen Granules were 219 million yuan, ranking 13th in the market
.
Top 20 Chinese patent medicine products for colds in physical pharmacies in Chinese cities
(Source: Minet)
Minet said that in urban physical pharmacy terminals, Lianhua Qingwen Capsule is stimulated by the epidemic, and its sales in 2020 will soar by 148.
59% to nearly 880 million yuan; in 2021, consumer purchases will return to rationality.
It has fallen by more than 30% year-on-year, but the overall level is still higher than that in 2019, and the product has become the best-selling exclusive traditional Chinese medicine OTC product
.
59% to nearly 880 million yuan; in 2021, consumer purchases will return to rationality.
It has fallen by more than 30% year-on-year, but the overall level is still higher than that in 2019, and the product has become the best-selling exclusive traditional Chinese medicine OTC product
.
In terms of terminals in public medical institutions, Lianhua Qingwen's sales in 2020 exceeded 2 billion yuan, a year-on-year increase of 85.
29%; in the first half of 2021, Lianhua Qingwen's sales exceeded that of 2019, a year-on-year increase of 31.
61%
.
29%; in the first half of 2021, Lianhua Qingwen's sales exceeded that of 2019, a year-on-year increase of 31.
61%
.
The outbreak of the epidemic in Hong Kong, the 28 yuan Lianhua Qingwen capsule in the pharmacy was fired to 100 yuan, and the price soared by 257%
.
.
28 yuan Lianhua Qingwen, the hype price can reach 100 yuan
On February 15, the Centre for Health Protection of the Department of Health of the Hong Kong Special Administrative Region Government announced that as of 0:00 that day, there were 1,619 new confirmed cases of new coronary pneumonia in Hong Kong (all local cases)
.
At present, the cumulative number of confirmed cases of new coronary pneumonia in Hong Kong is 26,670
.
.
At present, the cumulative number of confirmed cases of new coronary pneumonia in Hong Kong is 26,670
.
Recently, the Hong Kong media "Toutiao Daily" reported that under the severe epidemic situation in Hong Kong, the people set off a rush to buy Lianhua Qingwen
.
The reporter visited a number of pharmacies and found that Lianhua Qingwen was in short supply.
Some chain stores were out of stock a week ago
.
.
The reporter visited a number of pharmacies and found that Lianhua Qingwen was in short supply.
Some chain stores were out of stock a week ago
.
In addition, according to Hong Kong Wenhui.
com, a local pharmacy with Lianhua Qingwen did not sell it even if it had stock on that day
.
At present, the 28 yuan/box of Lianhua Qingwen capsules starts from 50 yuan and can reach up to 100 yuan, an increase of 257%
.
com, a local pharmacy with Lianhua Qingwen did not sell it even if it had stock on that day
.
At present, the 28 yuan/box of Lianhua Qingwen capsules starts from 50 yuan and can reach up to 100 yuan, an increase of 257%
.
Li Xiaowen, a doctor of traditional Chinese medicine in Hong Kong , pointed out that the effect of Lianhua Qingwen is to clear the fever and detoxify, and it is effective for the treatment and prevention of fever, nasal congestion, headache, sore throat and other mild symptoms
.
Many people in Hong Kong use Lianhua Qingwen as a body medicine, and use Chinese herbal medicines such as honeysuckle and forsythia to detoxify and relieve discomfort.
This is traditional Chinese folk wisdom, but the public should find a registered Chinese medicine practitioner for dispensing
.
.
Many people in Hong Kong use Lianhua Qingwen as a body medicine, and use Chinese herbal medicines such as honeysuckle and forsythia to detoxify and relieve discomfort.
This is traditional Chinese folk wisdom, but the public should find a registered Chinese medicine practitioner for dispensing
.
Behind the daily limit of the stock price is a good epidemic prevention strength
Affected by the related epidemic, the stock price of Yiling Pharmaceutical, the exclusive manufacturer of Lianhua Qingwen, showed signs of rapid rise yesterday
.
.
According to Oriental Fortune data, when the market opened on February 15, Yiling Pharmaceutical’s stock price was 21.
66 yuan, a decrease of -6.
03%.
In less than half an hour, the stock price rushed to 23.
99 yuan, an increase of 4.
08%, and the daily limit was directly raised; on the morning of February 16, the stock price overall Maintaining an upward trend, it reached 25.
03 yuan at around 10 points, an increase of 8.
59%
.
66 yuan, a decrease of -6.
03%.
In less than half an hour, the stock price rushed to 23.
99 yuan, an increase of 4.
08%, and the daily limit was directly raised; on the morning of February 16, the stock price overall Maintaining an upward trend, it reached 25.
03 yuan at around 10 points, an increase of 8.
59%
.
Behind the rise in stock prices, Lianhua Qingwen has become a star drug for epidemic prevention that has attracted much attention across the country, and is generally recognized
.
.
For example, in the fourth to eighth editions of the National "New Coronavirus Pneumonia Diagnosis and Treatment Program", as well as in the diagnosis and treatment programs of many provinces and cities across the country, Chinese patent medicines such as Lianhua Qingwen have been continuously recommended
.
.
In April 2020, Yiling Pharmaceutical issued a document stating that, with the approval of the State Food and Drug Administration, "new type of coronavirus pneumonia mild, common type" has been added to the original indications of Lianhua Qingwen Capsules and Lianhua Qingwen Granules
.
.
In addition, the international medical journal "Plant Medicine" published papers by academicians Zhong Nanshan, Li Lanjuan, and Zhang Boli also said that on the basis of conventional treatment, combined application of Lianhua Qingwen Capsules for 14 days can significantly improve the clinical cure rate of patients with new coronary pneumonia.
The treatment effect of fatigue, cough and other symptoms is obvious, and the safety is high
.
The treatment effect of fatigue, cough and other symptoms is obvious, and the safety is high
.
Not only at home, but also Lianhua Qingwen's response overseas is also good
.
.
In July 2021, Lianhua Qingwen was selected as the home treatment plan for mild patients with new coronary pneumonia in Cambodia .
This is the first case of Chinese medicines
entering foreign new coronary pneumonia treatment plans .
At present, Lianhua Qingwen has obtained registration approval or import license in nearly 30 countries and regions
.
This is the first case of Chinese medicines
entering foreign new coronary pneumonia treatment plans .
At present, Lianhua Qingwen has obtained registration approval or import license in nearly 30 countries and regions
.
Lianhua Qingwen Capsules ranked second in the pharmacy market
In addition to epidemic prevention, Lianhua Qingwen itself has achieved remarkable sales results
.
.
According to data from Minet.
com, in 2020, the sales of Chinese patent medicines for colds in Chinese urban physical pharmacies will exceed 11 billion yuan
.
Among them, Lianhua Qingwen Capsules were 1.
534 billion yuan, ranking second in the market, second only to Ganmaoling Granules; Lianhua Qingwen Granules were 219 million yuan, ranking 13th in the market
.
com, in 2020, the sales of Chinese patent medicines for colds in Chinese urban physical pharmacies will exceed 11 billion yuan
.
Among them, Lianhua Qingwen Capsules were 1.
534 billion yuan, ranking second in the market, second only to Ganmaoling Granules; Lianhua Qingwen Granules were 219 million yuan, ranking 13th in the market
.
Top 20 Chinese patent medicine products for colds in physical pharmacies in Chinese cities
(Source: Minet)
Minet said that in urban physical pharmacy terminals, Lianhua Qingwen Capsule is stimulated by the epidemic, and its sales in 2020 will soar by 148.
59% to nearly 880 million yuan; in 2021, consumer purchases will return to rationality.
It has fallen by more than 30% year-on-year, but the overall level is still higher than that in 2019, and the product has become the best-selling exclusive traditional Chinese medicine OTC product
.
59% to nearly 880 million yuan; in 2021, consumer purchases will return to rationality.
It has fallen by more than 30% year-on-year, but the overall level is still higher than that in 2019, and the product has become the best-selling exclusive traditional Chinese medicine OTC product
.
In terms of terminals in public medical institutions, Lianhua Qingwen's sales in 2020 exceeded 2 billion yuan, a year-on-year increase of 85.
29%; in the first half of 2021, Lianhua Qingwen's sales exceeded that of 2019, a year-on-year increase of 31.
61%
.
29%; in the first half of 2021, Lianhua Qingwen's sales exceeded that of 2019, a year-on-year increase of 31.
61%
.
The outbreak of the epidemic in Hong Kong, the 28 yuan Lianhua Qingwen capsule in the pharmacy was fired to 100 yuan, and the price soared by 257%
.
.
28 yuan Lianhua Qingwen, the hype price can reach 100 yuan
28 yuan Lianhua Qingwen, the hype price can reach 100 yuan On February 15, the Centre for Health Protection of the Department of Health of the Hong Kong Special Administrative Region Government announced that as of 0:00 that day, there were 1,619 new confirmed cases of new coronary pneumonia in Hong Kong (all local cases)
.
At present, the cumulative number of confirmed cases of new coronary pneumonia in Hong Kong is 26,670
.
.
At present, the cumulative number of confirmed cases of new coronary pneumonia in Hong Kong is 26,670
.
Recently, the Hong Kong media "Toutiao Daily" reported that under the severe epidemic situation in Hong Kong, the people set off a rush to buy Lianhua Qingwen
.
The reporter visited a number of pharmacies and found that Lianhua Qingwen was in short supply.
Some chain stores were out of stock a week ago
.
.
The reporter visited a number of pharmacies and found that Lianhua Qingwen was in short supply.
Some chain stores were out of stock a week ago
.
In addition, according to Hong Kong Wenhui.
com, a local pharmacy with Lianhua Qingwen did not sell it even if it had stock on that day
.
At present, the 28 yuan/box of Lianhua Qingwen capsules starts from 50 yuan and can reach up to 100 yuan, an increase of 257%
.
com, a local pharmacy with Lianhua Qingwen did not sell it even if it had stock on that day
.
At present, the 28 yuan/box of Lianhua Qingwen capsules starts from 50 yuan and can reach up to 100 yuan, an increase of 257%
.
Li Xiaowen, a doctor of traditional Chinese medicine in Hong Kong , pointed out that the effect of Lianhua Qingwen is to clear the fever and detoxify, and it is effective for the treatment and prevention of fever, nasal congestion, headache, sore throat and other mild symptoms
.
Many people in Hong Kong use Lianhua Qingwen as a body medicine, and use Chinese herbal medicines such as honeysuckle and forsythia to detoxify and relieve discomfort.
This is traditional Chinese folk wisdom, but the public should find a registered Chinese medicine practitioner for dispensing
.
Traditional Chinese Medicine Traditional Chinese Medicine.
Many people in Hong Kong use Lianhua Qingwen as a body medicine, and use Chinese herbal medicines such as honeysuckle and forsythia to detoxify and relieve discomfort.
This is traditional Chinese folk wisdom, but the public should find a registered Chinese medicine practitioner for dispensing
.
Behind the daily limit of the stock price is a good epidemic prevention strength
Behind the daily limit of the stock price is a good epidemic prevention strength Affected by the related epidemic, the stock price of Yiling Pharmaceutical, the exclusive manufacturer of Lianhua Qingwen, showed signs of rapid rise yesterday
.
enterprise enterprise enterprise.
According to Oriental Fortune data, when the market opened on February 15, Yiling Pharmaceutical’s stock price was 21.
66 yuan, a decrease of -6.
03%.
In less than half an hour, the stock price rushed to 23.
99 yuan, an increase of 4.
08%, and the daily limit was directly raised; on the morning of February 16, the stock price overall Maintaining an upward trend, it reached 25.
03 yuan at around 10 points, an increase of 8.
59%
.
66 yuan, a decrease of -6.
03%.
In less than half an hour, the stock price rushed to 23.
99 yuan, an increase of 4.
08%, and the daily limit was directly raised; on the morning of February 16, the stock price overall Maintaining an upward trend, it reached 25.
03 yuan at around 10 points, an increase of 8.
59%
.
Behind the rise in stock prices, Lianhua Qingwen has become a star drug for epidemic prevention that has attracted much attention across the country, and is generally recognized
.
.
For example, in the fourth to eighth editions of the National "New Coronavirus Pneumonia Diagnosis and Treatment Program", as well as in the diagnosis and treatment programs of many provinces and cities across the country, Chinese patent medicines such as Lianhua Qingwen have been continuously recommended
.
.
In April 2020, Yiling Pharmaceutical issued a document stating that, with the approval of the State Food and Drug Administration, "new type of coronavirus pneumonia mild, common type" has been added to the original indications of Lianhua Qingwen Capsules and Lianhua Qingwen Granules
.
.
In addition, the international medical journal "Plant Medicine" published papers by academicians Zhong Nanshan, Li Lanjuan, and Zhang Boli also said that on the basis of conventional treatment, combined application of Lianhua Qingwen Capsules for 14 days can significantly improve the clinical cure rate of patients with new coronary pneumonia.
The treatment effect of fatigue, cough and other symptoms is obvious, and the safety is high
.
The treatment effect of fatigue, cough and other symptoms is obvious, and the safety is high
.
Not only at home, but also Lianhua Qingwen's response overseas is also good
.
.
In July 2021, Lianhua Qingwen was selected as the home treatment plan for mild patients with new coronary pneumonia in Cambodia .
This is the first case of Chinese medicines
entering foreign new coronary pneumonia treatment plans .
At present, Lianhua Qingwen has obtained registration approval or import license in nearly 30 countries and regions
.
medicines medicines medicinesThis is the first case of Chinese medicines
entering foreign new coronary pneumonia treatment plans .
At present, Lianhua Qingwen has obtained registration approval or import license in nearly 30 countries and regions
.
Lianhua Qingwen Capsules ranked second in the pharmacy market
Lianhua Qingwen Capsules ranks second in the pharmacy pharmacy market In addition to epidemic prevention, Lianhua Qingwen itself has achieved remarkable sales results
.
.
According to data from Minet.
com, in 2020, the sales of Chinese patent medicines for colds in Chinese urban physical pharmacies will exceed 11 billion yuan
.
Among them, Lianhua Qingwen Capsules were 1.
534 billion yuan, ranking second in the market, second only to Ganmaoling Granules; Lianhua Qingwen Granules were 219 million yuan, ranking 13th in the market
.
com, in 2020, the sales of Chinese patent medicines for colds in Chinese urban physical pharmacies will exceed 11 billion yuan
.
Among them, Lianhua Qingwen Capsules were 1.
534 billion yuan, ranking second in the market, second only to Ganmaoling Granules; Lianhua Qingwen Granules were 219 million yuan, ranking 13th in the market
.
Top 20 Chinese patent medicine products for colds in physical pharmacies in Chinese cities
(Source: Minet)
Minet said that in urban physical pharmacy terminals, Lianhua Qingwen Capsule is stimulated by the epidemic, and its sales in 2020 will soar by 148.
59% to nearly 880 million yuan; in 2021, consumer purchases will return to rationality.
It has fallen by more than 30% year-on-year, but the overall level is still higher than that in 2019, and the product has become the best-selling exclusive traditional Chinese medicine OTC product
.
OTC OTC59% to nearly 880 million yuan; in 2021, consumer purchases will return to rationality.
It has fallen by more than 30% year-on-year, but the overall level is still higher than that in 2019, and the product has become the best-selling exclusive traditional Chinese medicine OTC product
.
In terms of terminals in public medical institutions, Lianhua Qingwen's sales in 2020 exceeded 2 billion yuan, a year-on-year increase of 85.
29%; in the first half of 2021, Lianhua Qingwen's sales exceeded that of 2019, a year-on-year increase of 31.
61%
.
29%; in the first half of 2021, Lianhua Qingwen's sales exceeded that of 2019, a year-on-year increase of 31.
61%
.
